Catalog No. |
TD-HW632046 |
Species reactivity |
Human |
Applications |
Research Grade Biosimilar |
Host species |
Humanized |
Isotype |
[VH-VH'-H-Gamma1-VL-VL'-C-kappa]-dimer |
Expression system |
Mammalian Cells |
Species |
Human |
Clonality |
Monoclonal |
Target |
IL13, NC30, Interleukin-13, IL-13, Binetrakin, B-cell stimulatory factor 1, Pitrakinra, Lymphocyte stimulatory factor 1, IL-4, BSF-1, IL4, Interleukin-4 |
Endotoxin level |
Please contact with the lab for this information. |
Purity |
>95% as determined by SDS-PAGE. |
Purification |
Protein A/G purified from cell culture supernatant. |
Accession |
P35225 & P05112 |
Form |
Liquid |
Storage buffer |
0.01M PBS, pH 7.4. |
Stability and Storage |
Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C long term. |
Alternate Names |
Bispecific, SAR156597, huTBTI3_2_1, CAS: 1399584-78-1 |
Background |
Romilkimab (SAR156597) is a chimeric humanized IG antibody that specifically targets IL-4 and IL13. |
Note |
For research use only. Not suitable for clinical or therapeutic use. |